These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 7666122

  • 1. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G, Berni F, Carratù L, Casalini A, Consigli G, D'Antò M, Gioia V, Molino A, Paizis G, Vaghi A.
    J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
    [Abstract] [Full Text] [Related]

  • 2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992 Apr; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

  • 3. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ.
    Clin Ther; 1992 Apr; 14(2):166-77. PubMed ID: 1611641
    [Abstract] [Full Text] [Related]

  • 4. Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis.
    Legnani D, Lombardo VM, Negretto GG, Beghi G, Caratozzolo O.
    J Hosp Infect; 1992 Nov; 22 Suppl A():69-74. PubMed ID: 1362752
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Aubier MA.
    Chemotherapy; 1997 Nov; 43(4):297-302. PubMed ID: 9209787
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
    Rademaker CM, Sips AP, Beumer HM, Hoepelman IM, Overbeek BP, Möllers MJ, Rozenberg-Arska M, Verhoef J.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 8. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA.
    J Int Med Res; 1996 Nov; 24(5):407-18. PubMed ID: 8895044
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Nov; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 10. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD001954. PubMed ID: 15497172
    [Abstract] [Full Text] [Related]

  • 11. [Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults].
    el Filali KM, el M'Daghri N, el Kabli H, Hajji M, Benbachir M, Himmich H.
    Pharmatherapeutica; 1989 Oct 18; 5(5):329-37. PubMed ID: 2748691
    [Abstract] [Full Text] [Related]

  • 12. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM, Möllers MJ, van Schie MH, Greefhorst AP, Schlösser NJ, Sinninghe Damsté EJ, van de Moosdijk CN, Dalinghaus WH, Eland ME, Mol SJ, Rozenberg-Arska M.
    Int J Antimicrob Agents; 1997 Jan 18; 9(3):141-6. PubMed ID: 9552709
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
    Balmes P, Clerc G, Dupont B, Labram C, Pariente R, Poirier R.
    Eur J Clin Microbiol Infect Dis; 1991 May 18; 10(5):437-9. PubMed ID: 1651860
    [Abstract] [Full Text] [Related]

  • 14. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan 18; 27(1):30-3. PubMed ID: 2663735
    [Abstract] [Full Text] [Related]

  • 15. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P.
    J Antimicrob Chemother; 1996 Jun 18; 37 Suppl C():93-101. PubMed ID: 8818850
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
    Martinot JB, Carr WD, Cullen S, Heredia Budo JL, Bauer K, MacLeod C, Sanguinetti CM, van Veldhuizen WC, Clarithromycin Once-a-Day Study Group.
    Adv Ther; 2001 Jun 18; 18(1):1-11. PubMed ID: 11512528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.